MedPath

TERUMO CORPORATION (DUBAI BRANCH)

🇦🇪United Arab Emirates
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

8

Active:0
Completed:2

Trial Phases

2 Phases

Phase 3:1
Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 3
1 (50.0%)
Phase 4
1 (50.0%)
No trials found

News

Global Diabetes Care Market Projected to Reach $62.73 Billion by 2032 Driven by Rising Disease Prevalence and Technology Advances

The global diabetes care market is expected to grow from $34.51 billion in 2025 to $62.73 billion by 2032, representing a compound annual growth rate of 8.9%.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.